Pierre Isnard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pierre Isnard has a total of 310 co-authors. Here are the top co-authors by number of shared publications:
Marion Rabant
Laboratoire d'Anatomie et Cytologie Pathologiques, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France; Institut Necker Enfants Malades (INEM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1151, Centre National de la Recherche Scientifique (CNRS) UMR8253, Université Paris Cité, Paris, France
10 shared publicationsJean-Paul Duong Van Huyen
Centre de Recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Université de Paris Cité, Team Inflammation, Complement and cancer, Paris, France
6 shared publications- Jean-Paul Duong Van Huyen
Pathology, Hôpital Universitaire Necker‐Enfants Malades Paris France
5 shared publications Alexandre Karras
Paris Cité University, Paris, France
4 shared publications- Benjamin D. Humphreys
Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA
4 shared publications - Fabiola Terzi
Université Paris Cité, INSERM UMR-U1151, CNRS UMR-8253, Institut Necker Enfants Malades, Paris, France
4 shared publications
Latest Publications
- Top Cited Papers
- 16 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6795) , eaea3219
HNF1B integrates signals in a feed-forward loop driving kidney disease progression
Chronic kidney disease (CKD), which affects more than 10% of the global population, may continue to progress even after the triggering insult has resolved, suggesting the involvement of self-sustaining mechanisms that remain poorly understood. Here, we identify this molecular circuitry, centered on the transcription factor HNF1B, a key regulator of renal epithelial identity. In adult kidneys, HNF1B loss disrupts epithelial differentiation and quiescence, induces replication stress, and triggers CKD. Conversely, CKD itself epigenetically suppresses HNF1B activity, creating a vicious cycle that amplifies disease progression. In a cohort of 900 patients, lower HNF1B activity correlated with greater CKD severity, linking this mechanism to common forms of the disease. These findings unify rare Mendelian and common complex kidney disorders and identify HNF1B loss as a driver of CKD.
- 16 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6795) , eaea3219
Top Cited PapersHNF1B integrates signals in a feed-forward loop driving kidney disease progression
Chronic kidney disease (CKD), which affects more than 10% of the global population, may continue to progress even after the triggering insult has resolved, suggesting the involvement of self-sustaining mechanisms that remain poorly understood. Here, we identify this molecular circuitry, centered on the transcription factor HNF1B, a key regulator of renal epithelial identity. In adult kidneys, HNF1B loss disrupts epithelial differentiation and quiescence, induces replication stress, and triggers CKD. Conversely, CKD itself epigenetically suppresses HNF1B activity, creating a vicious cycle that amplifies disease progression. In a cohort of 900 patients, lower HNF1B activity correlated with greater CKD severity, linking this mechanism to common forms of the disease. These findings unify rare Mendelian and common complex kidney disorders and identify HNF1B loss as a driver of CKD.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Les signatures moléculaires des maladies rénales
Les signatures moléculaires correspondent à l'analyse du transcriptome et dérivent de l'étude quantitative de l'ensemble des ARN messagers produits par des cellules dans des conditions spécifiques. L'intégration de ces données est une méthode efficace pour établir de nouveaux mécanismes physiopathologiques et identifier à terme de nouveaux biomarqueurs ou de nouvelles stratégies thérapeutiques. Ce travail de thèse s'est articulé autour de deux études distinctes : - L'étude d'une maladie rénale chronique monogénique lié à la perte d'expression d'HNF1β. - L'étude d'une maladie rénale aiguë dans le contexte de l'infection par le SARS-CoV-2. HNF1β est un facteur de transcription qui joue un rôle déterminant dans le développement rénal ainsi que le maintien de la structure et de la fonction du rein post natal. En dehors des manifestations rénales congénitales, la perte d'HNF1β entraine un déclin progressif de la fonction rénale conséquence de lésions d'atrophie tubulaire et de fibrose interstitielle. En utilisant un modèle murin d'invalidation spécifique tubulaire rénal et inductible du gène Hnf1b (Hnf1bΔTub), nous avons observé que les souris adultes Hnf1bΔTub présentaient une atrophie corticale d'origine tubulaire et des lésions de fibrose interstitielle. A l'échelle cellulaire, cette atrophie était liée à l'effet combiné d'une hypotrophie et d'une perte cellulaire par apoptose. Après une étude transcriptionnelle, nous avons paradoxalement identifié chez ces souris une signature relative à l'entrée en cycle cellulaire et à l'activation du facteur de transcription E2F. Ces modifications étaient associées à une augmentation de l'expression de la Cycline D1. Cette observation paradoxale d'entrée en cycle et d'atrophie tubulaire nous a mené à émettre l'hypothèse qu'un stress réplicatif pouvait être à l'origine de ce phénomène. Ainsi, nous avons observé, chez les souris Hnf1bΔTub, l'apparition précoce de dommages à l'ADN dans les cellules tubulaires en phase S et la présence de mécanismes de réponse à ces dommages par l'activation d'ATR et de P53. L'administration d'un inhibiteur Cycline D1-CDK (Palbociclib), a permis de prévenir partiellement le développement de lésions tubulaires et de fibrose interstitielle chez ces souris. Au total, nos travaux montrent que la perte tubulaire d'HNF1β est responsable d'atrophie tubulaire avec perte cellulaire secondaire à l'émergence d'un stress réplicatif dépendant de la cycline D1. Ces résultats, suggèrent un nouveau mécanisme de progression de la maladie rénale chronique secondaire à la perte d'HNF1β et proposent une nouvelle approche thérapeutique. L'insuffisance rénale aiguë (IRA) est l'une des complications les plus importantes chez les patients atteints de la COVID-19 et est considérée comme un facteur prédictif de sévérité de l'infection et de mortalité des patients. Nous avons étudié 32 biopsies rénales de patients COVID-19 vivants présentant une IRA ou une protéinurie. Nous avons effectué des analyses morphologiques et identifié une nouvelle entité lésionnelle caractérisée par l'association de microangiopathie thrombotique, d'une glomérulonéphrite endocapillaire et de dépôts de C3. Nous avons réalisé une recherche de l'ARN du SARS-CoV-2 par hybridation in situ et montré que ce virus infecte directement les cellules rénales. En parallèle, nous avons effectué une analyse transcriptionnelle des reins de patients COVID-19 et l'avons comparée à celles de patients sains et de patients avec IRA non liée à la COVID-19. Cette analyse moléculaire a mis en évidence des signatures moléculaires spécifiques dans les reins infectés par le virus et a identifié XAF1 comme un potentiel candidat lésionnel. Cette étude a démontré que le SARS-CoV-2 peut infecter directement les cellules rénales au stade initial de la défaillance rénale et a permis d'identifier des cibles moléculaires spécifiques permettant l'identification de nouvelles stratégies thérapeutiques potentielles.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Les signatures moléculaires des maladies rénales
Les signatures moléculaires correspondent à l'analyse du transcriptome et dérivent de l'étude quantitative de l'ensemble des ARN messagers produits par des cellules dans des conditions spécifiques. L'intégration de ces données est une méthode efficace pour établir de nouveaux mécanismes physiopathologiques et identifier à terme de nouveaux biomarqueurs ou de nouvelles stratégies thérapeutiques. Ce travail de thèse s'est articulé autour de deux études distinctes : - L'étude d'une maladie rénale chronique monogénique lié à la perte d'expression d'HNF1β. - L'étude d'une maladie rénale aiguë dans le contexte de l'infection par le SARS-CoV-2. HNF1β est un facteur de transcription qui joue un rôle déterminant dans le développement rénal ainsi que le maintien de la structure et de la fonction du rein post natal. En dehors des manifestations rénales congénitales, la perte d'HNF1β entraine un déclin progressif de la fonction rénale conséquence de lésions d'atrophie tubulaire et de fibrose interstitielle. En utilisant un modèle murin d'invalidation spécifique tubulaire rénal et inductible du gène Hnf1b (Hnf1bΔTub), nous avons observé que les souris adultes Hnf1bΔTub présentaient une atrophie corticale d'origine tubulaire et des lésions de fibrose interstitielle. A l'échelle cellulaire, cette atrophie était liée à l'effet combiné d'une hypotrophie et d'une perte cellulaire par apoptose. Après une étude transcriptionnelle, nous avons paradoxalement identifié chez ces souris une signature relative à l'entrée en cycle cellulaire et à l'activation du facteur de transcription E2F. Ces modifications étaient associées à une augmentation de l'expression de la Cycline D1. Cette observation paradoxale d'entrée en cycle et d'atrophie tubulaire nous a mené à émettre l'hypothèse qu'un stress réplicatif pouvait être à l'origine de ce phénomène. Ainsi, nous avons observé, chez les souris Hnf1bΔTub, l'apparition précoce de dommages à l'ADN dans les cellules tubulaires en phase S et la présence de mécanismes de réponse à ces dommages par l'activation d'ATR et de P53. L'administration d'un inhibiteur Cycline D1-CDK (Palbociclib), a permis de prévenir partiellement le développement de lésions tubulaires et de fibrose interstitielle chez ces souris. Au total, nos travaux montrent que la perte tubulaire d'HNF1β est responsable d'atrophie tubulaire avec perte cellulaire secondaire à l'émergence d'un stress réplicatif dépendant de la cycline D1. Ces résultats, suggèrent un nouveau mécanisme de progression de la maladie rénale chronique secondaire à la perte d'HNF1β et proposent une nouvelle approche thérapeutique. L'insuffisance rénale aiguë (IRA) est l'une des complications les plus importantes chez les patients atteints de la COVID-19 et est considérée comme un facteur prédictif de sévérité de l'infection et de mortalité des patients. Nous avons étudié 32 biopsies rénales de patients COVID-19 vivants présentant une IRA ou une protéinurie. Nous avons effectué des analyses morphologiques et identifié une nouvelle entité lésionnelle caractérisée par l'association de microangiopathie thrombotique, d'une glomérulonéphrite endocapillaire et de dépôts de C3. Nous avons réalisé une recherche de l'ARN du SARS-CoV-2 par hybridation in situ et montré que ce virus infecte directement les cellules rénales. En parallèle, nous avons effectué une analyse transcriptionnelle des reins de patients COVID-19 et l'avons comparée à celles de patients sains et de patients avec IRA non liée à la COVID-19. Cette analyse moléculaire a mis en évidence des signatures moléculaires spécifiques dans les reins infectés par le virus et a identifié XAF1 comme un potentiel candidat lésionnel. Cette étude a démontré que le SARS-CoV-2 peut infecter directement les cellules rénales au stade initial de la défaillance rénale et a permis d'identifier des cibles moléculaires spécifiques permettant l'identification de nouvelles stratégies thérapeutiques potentielles.
- Open Access
- 26 February 2026
- Published by Elsevier in Annales de Pathologie
Lymphoproliférations et lymphomes de l’immunodéprimé
- 26 February 2026
- Published by Elsevier in Annales de Pathologie
Open AccessLymphoproliférations et lymphomes de l’immunodéprimé
- Open Access
- 19 February 2026
- Published by Elsevier in Kidney International
- Vol. 109 (3) , 620-622
The Case | Unexplained post-transplant graft dysfunction in a rare metabolic disorder
- 19 February 2026
- Published by Elsevier in Kidney International
- Vol. 109 (3) , 620-622
Open AccessThe Case | Unexplained post-transplant graft dysfunction in a rare metabolic disorder
- Open Access
- 6 January 2026
- Published by Elsevier in Kidney International Reports
- Vol. 11 (3) , 103766
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor Nephritis
- 6 January 2026
- Published by Elsevier in Kidney International Reports
- Vol. 11 (3) , 103766
Open AccessImmune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor Nephritis
- 19 December 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (6) , 1174-1190
Clustered Mitochondrial Homolog Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease
Key Points: Lipocalin-2 inhibited clustered mitochondrial homolog (CLUH) activity and caused mitochondrial dysfunction. Loss of CLUH in kidneys triggered metabolic reprogramming and impaired mitochondrial structure. CLUH expression decreased with kidney injury and correlated with kidney function decline in patients. Background: Lipocalin-2 (LCN2) is a secreted protein involved in transporting hydrophobic molecules, regulating antibacterial responses and iron homeostasis. LCN2 expression increases after kidney damage and participates in CKD onset. We previously identified LCN2 as a regulator of mitochondrial dysfunction in renal tubular cells. This study aims to better understand LCN2's role in mitochondrial dysfunction and kidney pathology. Methods: LCN2 interactome was studied using mass spectrometry. The impact of LCN2 on clustered mitochondrial homolog (CLUH) activity was explored by immunofluorescence, Western blot, quantitative PCR, and RNA-immunoprecipitation. The role of CLUH on mitochondrial function in kidney was evaluated by RNAseq, metabolomics, electron microscopy, and immunochemistry using transgenic mice. Results: We characterized LCN2 interactome and identified CLUH in a multiprotein complex with LCN2. CLUH regulates mitochondrial homeostasis by binding mRNAs of nuclear-encoded mitochondrial proteins and promoting their translation. We demonstrated that LCN2 inhibited CLUH activity, leading to perinuclear mitochondrial clustering. We showed that CLUH was expressed in renal tubular cells and that its expression and activity decreased, while LCN2 expression increased after kidney injury leading to CKD. In human CKD patients, CLUH expression was inversely correlated with kidney lesions and kidney failure. CLUH genetic deletion in kidney nephron induced mitochondrial dysfunction and a subsequent interstitial fibrosis and kidney loss of function. Conclusions: This study shows that LCN2 forms a complex with CLUH and inhibits its activity, leading to perinuclear mitochondrial clustering. CLUH loss of function in renal tubular cells is associated with mitochondrial dysfunction and fibrosis, and in humans, CLUH expression inversely correlates with kidney lesions and loss of function.
- 19 December 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (6) , 1174-1190
Clustered Mitochondrial Homolog Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease
Key Points: Lipocalin-2 inhibited clustered mitochondrial homolog (CLUH) activity and caused mitochondrial dysfunction. Loss of CLUH in kidneys triggered metabolic reprogramming and impaired mitochondrial structure. CLUH expression decreased with kidney injury and correlated with kidney function decline in patients. Background: Lipocalin-2 (LCN2) is a secreted protein involved in transporting hydrophobic molecules, regulating antibacterial responses and iron homeostasis. LCN2 expression increases after kidney damage and participates in CKD onset. We previously identified LCN2 as a regulator of mitochondrial dysfunction in renal tubular cells. This study aims to better understand LCN2's role in mitochondrial dysfunction and kidney pathology. Methods: LCN2 interactome was studied using mass spectrometry. The impact of LCN2 on clustered mitochondrial homolog (CLUH) activity was explored by immunofluorescence, Western blot, quantitative PCR, and RNA-immunoprecipitation. The role of CLUH on mitochondrial function in kidney was evaluated by RNAseq, metabolomics, electron microscopy, and immunochemistry using transgenic mice. Results: We characterized LCN2 interactome and identified CLUH in a multiprotein complex with LCN2. CLUH regulates mitochondrial homeostasis by binding mRNAs of nuclear-encoded mitochondrial proteins and promoting their translation. We demonstrated that LCN2 inhibited CLUH activity, leading to perinuclear mitochondrial clustering. We showed that CLUH was expressed in renal tubular cells and that its expression and activity decreased, while LCN2 expression increased after kidney injury leading to CKD. In human CKD patients, CLUH expression was inversely correlated with kidney lesions and kidney failure. CLUH genetic deletion in kidney nephron induced mitochondrial dysfunction and a subsequent interstitial fibrosis and kidney loss of function. Conclusions: This study shows that LCN2 forms a complex with CLUH and inhibits its activity, leading to perinuclear mitochondrial clustering. CLUH loss of function in renal tubular cells is associated with mitochondrial dysfunction and fibrosis, and in humans, CLUH expression inversely correlates with kidney lesions and loss of function.
- Open Access
- 15 December 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (4) , 711-727
The Spatially Resolved Kidney Transcriptome Signatures in Rat Models of Trauma-Induced Acute Kidney Injury
Background: Trauma is a leading global cause of death, and acute kidney injury (AKI) significantly worsens outcomes. Hemorrhagic shock (HS) and rhabdomyolysis (RM) are major contributors, yet their individual and combined effects on the kidney remain poorly defined. Methods: Using a clinically relevant rat model that closely mimics human trauma, we performed bulk and spatial transcriptomics to characterize early renal responses to HS, RM, and their combination (RM-HS). Commercial mouse spatial transcriptomics probes were successfully applied to rat kidney tissue, enabling cost-effective and region-specific gene expression profiling. Results: RM emerged as the dominant driver of transcriptional changes, while RM-HS triggered a synergistic, mortality-associated response. Comparative analyses revealed distinct regional and molecular signatures: HS suppressed metabolic activity, whereas RM induced widespread upregulation of inflammatory and stress-response pathways. Conclusions: We propose a mechanistic framework linking these traumatic insults to tubular cell injury and death, with mitochondrial dysfunction, dysregulated lipid metabolism, PLIN2 expression, and ferroptosis as central components. This integrative model advances our understanding of trauma-induced renal injury and may enable the identification of novel biomarkers and therapeutic strategies to mitigate AKI severity in trauma patients.
- 15 December 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (4) , 711-727
Open AccessThe Spatially Resolved Kidney Transcriptome Signatures in Rat Models of Trauma-Induced Acute Kidney Injury
Background: Trauma is a leading global cause of death, and acute kidney injury (AKI) significantly worsens outcomes. Hemorrhagic shock (HS) and rhabdomyolysis (RM) are major contributors, yet their individual and combined effects on the kidney remain poorly defined. Methods: Using a clinically relevant rat model that closely mimics human trauma, we performed bulk and spatial transcriptomics to characterize early renal responses to HS, RM, and their combination (RM-HS). Commercial mouse spatial transcriptomics probes were successfully applied to rat kidney tissue, enabling cost-effective and region-specific gene expression profiling. Results: RM emerged as the dominant driver of transcriptional changes, while RM-HS triggered a synergistic, mortality-associated response. Comparative analyses revealed distinct regional and molecular signatures: HS suppressed metabolic activity, whereas RM induced widespread upregulation of inflammatory and stress-response pathways. Conclusions: We propose a mechanistic framework linking these traumatic insults to tubular cell injury and death, with mitochondrial dysfunction, dysregulated lipid metabolism, PLIN2 expression, and ferroptosis as central components. This integrative model advances our understanding of trauma-induced renal injury and may enable the identification of novel biomarkers and therapeutic strategies to mitigate AKI severity in trauma patients.
- Open Access
- 30 October 2025
- Published by Elsevier in Kidney International
- Vol. 109 (1) , 64-72
Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney disease
- 30 October 2025
- Published by Elsevier in Kidney International
- Vol. 109 (1) , 64-72
Open AccessDrug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney disease
- Top Cited PapersOpen Access
- 14 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Multimodal spatial transcriptomic characterization of mouse kidney injury and repair
The transition from acute kidney injury to chronic kidney disease is characterized by significant changes in the cellular composition and molecular interactions within the kidney. Utilizing high-resolution Xenium and whole transcriptome Visium spatial transcriptomics platforms, we analyze over a million cells on 12 male mouse kidneys across six stages of renal injury and repair. We define and validate 20 major kidney cell populations and delineate distinct cellular neighborhoods through this multimodal spatial analysis. We further reveal a specific fibro-inflammatory niche enriched in failed-repair proximal tubule cells, fibroblasts, and immune cells, with conserved neighborhood gene signatures across mouse and human. Within this niche, we predict Runx2 as a key upstream regulator, along with platelet-derived growth factor and integrin beta-2 signaling pathways shaping the fibrogenic microenvironment. Altogether, our study provides deep insights into the cellular and molecular dynamics during kidney injury and repair and establishes a comprehensive multimodal analytical framework applicable to other spatial omics studies.
- 14 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Top Cited PapersOpen AccessMultimodal spatial transcriptomic characterization of mouse kidney injury and repair
The transition from acute kidney injury to chronic kidney disease is characterized by significant changes in the cellular composition and molecular interactions within the kidney. Utilizing high-resolution Xenium and whole transcriptome Visium spatial transcriptomics platforms, we analyze over a million cells on 12 male mouse kidneys across six stages of renal injury and repair. We define and validate 20 major kidney cell populations and delineate distinct cellular neighborhoods through this multimodal spatial analysis. We further reveal a specific fibro-inflammatory niche enriched in failed-repair proximal tubule cells, fibroblasts, and immune cells, with conserved neighborhood gene signatures across mouse and human. Within this niche, we predict Runx2 as a key upstream regulator, along with platelet-derived growth factor and integrin beta-2 signaling pathways shaping the fibrogenic microenvironment. Altogether, our study provides deep insights into the cellular and molecular dynamics during kidney injury and repair and establishes a comprehensive multimodal analytical framework applicable to other spatial omics studies.
- 25 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (804) , eadq7825
Podocyte-specific YAP activation triggers crescentic glomerulonephritis through cross-talk with parietal epithelial cells
Crescentic glomerulonephritis (cGN) is a severe kidney pathology characterized by the aberrant proliferation of epithelial cells, leading to crescent formation within the Bowman’s space. The molecular pathways involved in crescent formation remain poorly understood despite its clinical relevance. Given the mechanical stress experienced by podocytes, likely exacerbated in cGN, we hypothesized that activation of the mechanosensor yes-associated protein 1 (YAP), an effector of the Hippo pathway, may contribute to the development of cGN. Here, we demonstrate activation of YAP and its target genes in the nephrotoxic nephritis model, a murine model of cGN. Mechanistically, podocyte-specific hyperactivation of YAP (YAP 5SA ) in transgenic mice led to cell-autonomous hypertrophy of podocytes and non–cell-autonomous activation and proliferation of parietal epithelial cells (PECs), culminating in crescents. Transcriptomic profiling in a human podocyte cell line expressing the same YAP 5SA isoform revealed the reactivation of developmental programs within differentiated podocytes and identified the phosphoinositide 3-kinase–protein kinase B–mechanistic target of rapamycin (PI3K-Akt-mTOR) signaling pathway as a candidate involved in YAP-induced podocyte hypertrophy. Furthermore, this analysis identified connective tissue growth factor (CTGF) and heparin-binding epidermal growth factor–like growth factor (HB-EGF) as potential mediators in the cross-talk between YAP-activated podocytes and PECs, driving PEC hyperplasia. Collectively, these findings highlight the pivotal role of YAP in the pathogenesis of cGN and indicate that targeting YAP signaling could be a promising therapeutic strategy for this severe kidney disease.
- 25 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (804) , eadq7825
Podocyte-specific YAP activation triggers crescentic glomerulonephritis through cross-talk with parietal epithelial cells
Crescentic glomerulonephritis (cGN) is a severe kidney pathology characterized by the aberrant proliferation of epithelial cells, leading to crescent formation within the Bowman’s space. The molecular pathways involved in crescent formation remain poorly understood despite its clinical relevance. Given the mechanical stress experienced by podocytes, likely exacerbated in cGN, we hypothesized that activation of the mechanosensor yes-associated protein 1 (YAP), an effector of the Hippo pathway, may contribute to the development of cGN. Here, we demonstrate activation of YAP and its target genes in the nephrotoxic nephritis model, a murine model of cGN. Mechanistically, podocyte-specific hyperactivation of YAP (YAP 5SA ) in transgenic mice led to cell-autonomous hypertrophy of podocytes and non–cell-autonomous activation and proliferation of parietal epithelial cells (PECs), culminating in crescents. Transcriptomic profiling in a human podocyte cell line expressing the same YAP 5SA isoform revealed the reactivation of developmental programs within differentiated podocytes and identified the phosphoinositide 3-kinase–protein kinase B–mechanistic target of rapamycin (PI3K-Akt-mTOR) signaling pathway as a candidate involved in YAP-induced podocyte hypertrophy. Furthermore, this analysis identified connective tissue growth factor (CTGF) and heparin-binding epidermal growth factor–like growth factor (HB-EGF) as potential mediators in the cross-talk between YAP-activated podocytes and PECs, driving PEC hyperplasia. Collectively, these findings highlight the pivotal role of YAP in the pathogenesis of cGN and indicate that targeting YAP signaling could be a promising therapeutic strategy for this severe kidney disease.